All data are based on the daily closing price as of September 18, 2025
s
Shinpoong Pharm
019170.KO
9.49 USD
-0.02
-0.21%
Overview
Last close
9.49 usd
Market cap
467.60M usd
52 week high
14.06 usd
52 week low
4.50 usd
Target price
4.16 usd
Valuation
P/E
N/A
Forward P/E
N/A
Price/Sales
2.885
Price/Book Value
2.6284
Enterprise Value
482.35M usd
EV/Revenue
2.9715
EV/EBITDA
129.6119
Key financials
Revenue TTM
162.33M usd
Gross Profit TTM
65.31M usd
EBITDA TTM
1.78M usd
Earnings per Share
N/A usd
Dividend
N/A usd
Total assets
249.46M usd
Net debt
8.99M usd
About
Shinpoong Pharmaceutical Co.,Ltd, together with its subsidiaries, manufactures and sells pharmaceutical products in South Korea. The company offers cephalosporin antibiotics; penicillin antibiotics; and finished products, as well as antivirals, anticancer drugs, painkillers, anti-inflammatory products, and anthelmintics. It provides active pharmaceutical ingredients; Pyramax, an anti-malarial drug; and drugs for treating hypercholesterolemia, knee osteoarthritis and shoulder periarthritis, and surgical adhesion barrier; prescription drugs; wound dressings; health functional food; and over the counter products. In addition, the company engages in business management and exports its products to approximately 50 countries. The company was founded in 1962 and is headquartered in Seoul, South Korea.